Skip to Main Content

Paper Details

A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.
Mol Cancer Res
10
2019
AKT, Docetaxel, European American (EA) prostate cancer cell lines, FGFR, FGFR3, FGFR3 Splice Variant, FGFR3 splice variant, FGFR3-L, FGFR3-S, LNCaP, PC, PC-3, PC-3 cells, Prostate Cancer, STAT3, docetaxel, dovitinib, exon 14, mice, nucleotides, patient, prostate cancer, ribosomal S6, tumor
Author NameAffiliation
Travers ChingUniversity of Hawaii
Lana X GarmireUniversity of Michigan ann arbor
Lana X GarmireUniversity of Michigan ann arbor
  • 1 - 3

Datasets

Release 1.2